Analyst Activity – Benchmark Raises Its Price Target On NASDAQ:BEAT – BioTelemetry (NASDAQ:BEAT) to $46.00

Analyst Ratings For NASDAQ:BEAT – BioTelemetry (NASDAQ:BEAT)

Story continues below

Today, Benchmark raised its price target on NASDAQ:BEAT – BioTelemetry (NASDAQ:BEAT) to $46.00 per share.

Some recent analyst ratings include

  • 2/23/2018-Dougherty & Co Reiterated Rating of Buy .
  • 10/26/2017-Raymond James initiated coverage with a Outperform rating.
  • 10/23/2017-SunTrust Banks initiated coverage with a Buy rating.
  • 9/15/2017-Off Wall Street initiated coverage with a Sell rating.
  • 8/10/2017-Sidoti Reiterated Rating of Buy.
  • 7/14/2017-Lake Street Capital Reiterated Rating of Buy.

Recent Insider Trading Activity For NASDAQ:BEAT – BioTelemetry (NASDAQ:BEAT)
NASDAQ:BEAT – BioTelemetry (NASDAQ:BEAT) has insider ownership of 9.60% and institutional ownership of 87.29%.

  • On 3/13/2018 Fred Broadway, Insider, sold 54,158 with an average share price of $34.17 per share and the total transaction amounting to $1,850,578.86.
  • On 5/15/2017 Robert J. Rubin, Director, sold 15,000 with an average share price of $28.14 per share and the total transaction amounting to $422,100.00.
  • On 3/20/2017 Fred Broadway, SVP, sold 3,429 with an average share price of $26.90 per share and the total transaction amounting to $92,240.10.
  • On 2/27/2017 George Hrenko, SVP, sold 126,043 with an average share price of $25.95 per share and the total transaction amounting to $3,270,815.85.
  • On 2/21/2017 Fred Broadway, SVP, sold 8,070 with an average share price of $24.81 per share and the total transaction amounting to $200,216.70.
  • On 9/19/2016 George Hrenko, SVP, sold 1,061 with an average share price of $18.50 per share and the total transaction amounting to $19,628.50.
  • On 9/13/2016 Heather C Getz, CFO, sold 5,866 with an average share price of $18.23 per share and the total transaction amounting to $106,937.18.

Recent Trading Activity for NASDAQ:BEAT – BioTelemetry (NASDAQ:BEAT)
Shares of NASDAQ:BEAT – BioTelemetry closed the previous trading session at 38.45 up +4.70 13.93% with shares trading hands.

An ad to help with our costs